Point72 Hong Kong LTD Heron Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $67,877 - $137,031	25,518 New	25,518 $108,000
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $19,216 - $52,552	-8,355 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $38,683 - $83,048	8,355 New	8,355 $48,000
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $56,671 - $85,516	-6,787 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $48,593 - $71,955	4,797 Added 241.06%	6,787 $73,000
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $26,407 - $36,775	1,990 New	1,990 $31,000
Q2 2020 Aug 14, 2020	SELL	$10.89 - $21.47 $1,927 - $3,800	-177 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $1,810 - $4,347	177 New	177 $2,000
Q4 2018 Feb 14, 2019	SELL	$22.03 - $32.01 $1,035 - $1,504	-47 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $59,310 - $80,760	-1,977 Reduced 97.68%	47 $1,000
Q2 2018 Aug 14, 2018	BUY	$26.4 - $42.0 $53,433 - $85,008	2,024 New	2,024 $79,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.